DSAM Partners (London) Ltd - Q4 2020 holdings

$854 Million is the total value of DSAM Partners (London) Ltd's 58 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was - .

 Value Shares↓ Weighting
MU NewMICRON TECHNOLOGY INC$48,430,000644,186
+100.0%
5.67%
MP NewMP MATERIALS CORP$32,170,0001,000,000
+100.0%
3.77%
VNT NewVONTIER CORPORATION$29,253,000875,837
+100.0%
3.42%
EXPE NewEXPEDIA GROUP INC$24,140,000182,327
+100.0%
2.83%
STPK NewSTAR PEAK ENERGY TRANSITIONcl a$20,918,0001,022,381
+100.0%
2.45%
QRVO NewQORVO INC$20,807,000125,141
+100.0%
2.44%
RMO NewROMEO POWER INC$19,526,000868,196
+100.0%
2.29%
CCK NewCROWN HLDGS INC$18,397,000183,603
+100.0%
2.15%
IPV NewINTERPRIVATE ACQUISITION COR$17,530,0001,205,611
+100.0%
2.05%
BFT NewFOLEY TRASIMENE ACQUISITION$17,483,0001,157,829
+100.0%
2.05%
OZON NewOZON HLDGS PLCsponsored ads$14,519,000350,623
+100.0%
1.70%
VTRS NewVIATRIS INC$14,308,000763,485
+100.0%
1.68%
GCMG NewGCM GROSVENOR INC$13,320,0001,000,000
+100.0%
1.56%
PDD NewPINDUODUO INCsponsored ads$12,399,00069,786
+100.0%
1.45%
ON NewON SEMICONDUCTOR CORP$11,585,000353,942
+100.0%
1.36%
AR NewANTERO RESOURCES CORP$11,384,0002,088,824
+100.0%
1.33%
BOACU NewBLUESCAPE OPPORTUNITIES ACQUunit 99/99/9999$11,160,0001,000,000
+100.0%
1.31%
DIS NewDISNEY WALT CO$10,508,00058,000
+100.0%
1.23%
CVNA NewCARVANA COcl a$10,421,00043,506
+100.0%
1.22%
VRTX NewVERTEX PHARMACEUTICALS INC$9,330,00039,477
+100.0%
1.09%
RUN NewSUNRUN INC$8,728,000125,798
+100.0%
1.02%
SMAR NewSMARTSHEET INC$8,585,000123,895
+100.0%
1.00%
BBIO NewBRIDGEBIO PHARMA INC$7,107,00099,937
+100.0%
0.83%
KRON NewKRONOS BIO INC$5,977,000200,096
+100.0%
0.70%
OPEN NewOPENDOOR TECHNOLOGIES INC$5,335,000234,723
+100.0%
0.62%
KRYS NewKRYSTAL BIOTECH INC$5,256,00087,608
+100.0%
0.62%
SRAC NewSTABLE RD ACQUISITION CORP$4,938,000274,949
+100.0%
0.58%
IOVA NewIOVANCE BIOTHERAPEUTICS INC$4,740,000102,157
+100.0%
0.56%
NCR NewNCR CORP NEW$3,006,00080,000
+100.0%
0.35%
CLDX NewCELLDEX THERAPEUTICS INC NEW$2,978,000170,000
+100.0%
0.35%
VIPS NewVIPSHOP HOLDINGS LIMITEDsponsored ads a$2,136,00076,000
+100.0%
0.25%
EPAM NewEPAM SYS INC$1,792,0005,000
+100.0%
0.21%
AFIB NewACUTUS MED INC$1,525,00052,925
+100.0%
0.18%
IMTX NewIMMATICS N.V$806,00074,736
+100.0%
0.09%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AMAZON COM INC16Q2 20219.8%
ACTIVISION BLIZZARD INC15Q3 202012.9%
ALPHABET INC15Q3 202110.0%
YANDEX N V14Q2 20214.6%
KITE PHARMA INC13Q3 20176.1%
ALIBABA GROUP HLDG LTD13Q3 20206.3%
ALLOGENE THERAPEUTICS INC12Q3 20213.6%
MICROSOFT CORP11Q3 202110.3%
ELECTRONIC ARTS INC11Q2 20189.2%
ANTHEM INC11Q1 202012.5%

View DSAM Partners (London) Ltd's complete holdings history.

Latest filings
TypeFiled
13F-HR2021-11-15
13F-HR2021-08-16
13F-HR2021-05-17
13F-HR2021-02-16
13F-HR/A2020-11-18
13F-HR/A2020-11-18
13F-HR/A2020-11-18
13F-HR2020-11-16
13F-HR2020-08-14
13F-HR/A2020-05-15

View DSAM Partners (London) Ltd's complete filings history.

Compare quarters

Export DSAM Partners (London) Ltd's holdings